The Medical News

The Medical News

Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma. This form of cancer in children, which occurs in specialized nerve cells in the sympathetic nervous system, may be life-threatening. In the long term the discovery, described in the latest issue of the scientific journal Nature Communications , may result in a new form of treatment for children in whom the disease is severe or at an advanced stage. The new treatment is based on activating a receptor protein, CNR2 (cannabinoid receptor 2), in the nervous system. A highly unusual method enabled this particular protein to be applied therapeutically. Instead of using traditional methods of drug development, this research group has developed a new computer algorithm capable of combining massive quantities of genetic and pharmacological data ('big data') from European and American hospitals and universities. The algorithm then suggested new treatments that could influence the basic mechanisms of the disease. We were astonished when the algorithm came up with completely new ideas for treatment, such as CNR2, that no one has ever discussed in this context. So we decided to investigate this further in the lab." Sven Nelander, senior lecturer at Uppsala University's Department of Immunology, Genetics and Pathology, who is in charge of the study Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More